NCT00355992View on ClinicalTrials.gov

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

TerminatedOBSERVATIONAL
Enrollment

1,250

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

December 31, 2007

Conditions
Heart Disease, IschemicIschemia, MyocardialIschemic Heart DiseaseUnstable Angina
Trial Locations (5)

44195

Cleveland Clinic, Cleveland

Unknown

Massachusetts General Hospital, Boston

Dartmouth Medical Center, Lebanon

Vanderbilt University, Nashville

L8L2X2

Hamilton General Hospital, Hamilton

Sponsors
All Listed Sponsors
lead

Inverness Medical Innovations

INDUSTRY

NCT00355992 - The Ischemia Modified Albumin In Diagnosing Ischemic New Events | Biotech Hunter | Biotech Hunter